Clinical Trials Directory

Trials / Sponsors / Beijing Minhai Biotechnology Co., Ltd

Beijing Minhai Biotechnology Co., Ltd

Industry · 9 registered clinical trials — 1 currently recruiting.

StatusTrialPhaseStarted
RecruitingA Phase 3 Study to Evaluate the Immunogenicity and Safety of Minhai's PCV13-DT/TT Vaccine As Compared to Pfize
Pneumococcal Vaccines, Pneumococcal Infections
Phase 32024-11-01
CompletedA Study to Evaluate Safety and Immunogenicity of Sequential Vaccination of Sabin Inactivated Poliomyelitis Vac
Poliomyelitis
Phase 32023-03-08
UnknownA Study to Evaluate Safety and Immunogenicity of Inactivated SARS-CoV-2 Vaccine (Vero Cells) in Healthy Popula
COVID-19
Phase 22020-10-27
UnknownA Safety and Immunogenicity Study of Inactivated SARS-CoV-2 Vaccine (Vero Cells) in Healthy Population Aged 18
COVID-19
Phase 12020-10-07
CompletedA Study to Evaluate Persistence of Immunity of PCV13 in Healthy Population Aged 2 Months，7 Months-5 Years
Pneumonia
Phase 42019-09-26
CompletedPhase III Clinical Trial of Sabin Strain Inactivated Poliovirus Vaccine (Vero Cell)
Poliomyelitis
Phase 32017-08-21
UnknownSafety and Immunogenicity of Haemophilus Influenzae Type b Conjugate Vaccine，Freeze-dried
Haemophilus Influenzae Type b Infections
Phase 32014-09-01
CompletedImmunogenicity and Safety of Group A, C, Y and W135 Meningococcal Polysaccharide Vaccine
Meningitis
Phase 32013-11-01
CompletedImmunogenicity and Safety of Meningococcal (A, C, Y and W135) Conjugate Vaccine
Meningitis
Phase 32013-10-01